In a placebo-controlled, randomized, double-blind clinical study, Citrofen was shown to offer several potential health benefits for those suffering from osteoarthritis of the knee. One key benefit is the improvement of knee-joint pain/flexibility as measured by LAI (Lequesne Algofunctional Index) scores. Another is a reduction in inflammation as measured by C-reactive protein (CRP) levels. As [read more]

In a placebo-controlled, randomized, double-blind clinical study of subjects diagnosed with osteoarthritis of the knee, Citrofen was shown to not only yield anti-inflammatory benefits, but also promote loss of body weight. Overweight people are at high risk for developing osteoarthritis of the knee, and studies have consistently shown that overweight women have four times the [read more]